AUSTIN, Texas–(BUSINESS WIRE)–Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.
On September 2, 2021, the Compensation Committee…
Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Share this article
More News
Have we been measuring crypto adoption all wrong?
July 1, 2026
Trump reports US$1.4bn crypto earnings
July 1, 2026
